GlassScriptPhysician profile
Stanley Voigt
NPI 1154641751
$5,864.25
in general payments reported to CMS, 2019-2025
21 companies · $2,311 in 2025
The $2,311 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $294 · 2021: $435 · 2022: $1,105 · 2023: $671 · 2024: $885 · 2025: $2,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,058 · Travel and Lodging: $791 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,057.90 |
| Travel and Lodging | $790.94 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $1,223.18 | 2019-2025 | |
| Stryker Corporation | $1,116.00 | 2022-2025 | Scopis Ent, Audion Et Dilation System, Clarifix |
| Regeneron Healthcare Solutions, INC. | $1,034.55 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $551.61 | 2021-2025 | Nucala |
| Genzyme Corporation | $472.76 | 2019-2025 | |
| Aerin Medical INC. | $372.19 | 2019-2025 | |
| Medtronic, INC. | $177.01 | 2025 | Propel, Stealthstation S8 Platform |
| Acclarent, INC | $131.07 | 2020-2024 | Trudi Nav Cable |
| Inspire Medical Systems, INC. | $118.95 | 2024-2025 | Inspire |
| Alk-Abello, INC | $115.58 | 2020-2025 | Neffy, Timothy, Standardized, Odactra |
| Intersect Ent, INC. | $101.58 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $87.26 | 2022 | |
| Checkpoint Surgical, INC | $77.44 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $75.94 | 2025 | Xhance |
| Greer Laboratories, INC. | $69.83 | 2023-2024 | Oralair |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33.19 | 2025 | Tezspire |
| Acera Surgical, INC. | $26.96 | 2024 | Restrata Wound Matrix |
| Davol INC. | $23.40 | 2020 | |
| 3b Medical, INC. | $23.35 | 2025 | Luna |
| Integra Lifesciences Corporation | $17.44 | 2021 | |
| Phadia US INC. | $14.96 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Voigt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.